USPTO serial 98151134
Serial No. 98151134
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 12, 2025
- Examiner
- MIZELLE HOWARD, DEZMONA JULYE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 98151134?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Recursion Pharmaceuticals, Inc.
Salt Lake City, UT
Recursion Pharmaceuticals, Inc.
Salt Lake City, UT
Recursion Pharmaceuticals, Inc.
Salt Lake City, UT
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David Johnson
David Johnson WORKMAN NYDEGGER60 E SOUTH TEMPLESUITE 1000SALT LAKE CITY, UT 84111Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical research and development services; Scientific research and development of pharmaceutical preparations; Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; Contract research services in support of scientific research and development of pharmaceutical preparations; Technical consultancy and services in relation to technical research in the field of pharmaceuticals; Consultancy in relation to scientific research in the field of pharmaceuticals; Providing medical research and scientific research information in the field of medicine and pharmaceuticals; Drug discovery services; Drug use discovery services; scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; Providing an online searchable database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding; Providing an online database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding | ACTIVE | Jul 23, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 12, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 12, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 21, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 7, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 7, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 1, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 1, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 31, 2025 | IUAF | USE AMENDMENT FILED | — |
| Mar 31, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 31, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 31, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 1, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 6, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 6, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 17, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 29, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 28, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 28, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 28, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 26, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 25, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 29, 2023 | NWAP | NEW APPLICATION ENTERED | — |